Printer Friendly

First Patient Treated in US Study of Next Generation Aortic Heart Valve.

M2 PHARMA-November 11, 2015-First Patient Treated in US Study of Next Generation Aortic Heart Valve

(C)2015 M2 COMMUNICATIONS

- US-based not-for-profit healthcare system PinnacleHealth's CardioVascular Institute has enrolled the first patient in Pennsylvania in a randomised trial studying a new heart valve to treat aortic valve disorders, the organisation said.

Harrisburg Hospital is the only trial site inPennsylvania.

This study represents the next wave of research with aortic valves that conform to the patient's anatomy.

According to an article published in the Journal of the American College of Cardiology, aortic stenosis is the most common valvular heart disease in developed countries with prevalence estimated between 3 and 23%.

AS mainly affects older people, due to scarring and calcium buildup in the valve cusp. With a growing elderly population, AS is anticipated to become a major public health concern.

SALUS is a prospective, multicenter clinical trial of the Direct Flow Medical Transcatheter Aortic Valve System, which will enroll 912 subjects in up to 45 sites in the US Mubashir Mumtaz, MD, FACS, FACC, chief of cardiothoracic surgery, and William Bachinsky, MD, FACC, medical director of vascular services, serve as co-principal investigators locally at PinnacleHealth.

The purpose of SALUS is to compare the Direct Flow Medical system to the commercially available Medtronic CoreValve in high- and extreme-risk patients with severe symptomatic aortic stenosis. The Direct Flow Medical valve has a double-ring, polymer-based frame, while the Medtronic CoreValve is held by a metal frame.

According to PinnacleHealth, the unique design of the investigational device allows the valve to conform to the patient's anatomy.

Unlike other transcatheter aortic valve replacement procedures, the investigational valve does not require rapid pacing of the heart through electrical stimulation.

At PinnacleHealth, there is a team approach to transcatheter aortic valve replacement procedures. TAVR procedures, such as those using Direct Flow Medical and CoreValve valves, involve direct care by both a cardiothoracic surgeon and interventional cardiologist in a specially equipped operating room.

PinnacleHealth is a not-for-profit healthcare system operating in Central Pennsylvania since 1873.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Article Type:Report
Date:Nov 11, 2015
Words:346
Previous Article:Reflux Complaints Increase During Holiday Season, Survey Finds.
Next Article:SiTime, Abracon Partner to Expand Availability of MEMS Oscillators.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters